Metabolic Cardiomyopathies and Cardiac Defects in Inherited Disorders of Carbohydrate Metabolism: A Systematic Review

Abstract

Heart failure (HF) is a progressive chronic disease that remains a primary cause of death worldwide, affecting over 64 million patients. HF can be caused by cardiomyopathies and congenital cardiac defects with monogenic etiology. The number of genes and monogenic disorders linked to development of cardiac defects is constantly growing and includes inherited metabolic disorders (IMDs). Several IMDs affecting various metabolic pathways have been reported presenting cardiomyopathies and cardiac defects. Considering the pivotal role of sugar metabolism in cardiac tissue, including energy production, nucleic acid synthesis and glycosylation, it is not surprising that an increasing number of IMDs linked to carbohydrate metabolism are described with cardiac manifestations. In this systematic review, we offer a comprehensive overview of IMDs linked to carbohydrate metabolism presenting that present with cardiomyopathies, arrhythmogenic disorders and/or structural cardiac defects. We identified 58 IMDs presenting with cardiac complications: 3 defects of sugar/sugar-linked transporters (GLUT3, GLUT10, THTR1); 2 disorders of the pentose phosphate pathway (G6PDH, TALDO); 9 diseases of glycogen metabolism (GAA, GBE1, GDE, GYG1, GYS1, LAMP2, RBCK1, PRKAG2, G6PT1); 29 congenital disorders of glycosylation (ALG3, ALG6, ALG9, ALG12, ATP6V1A, ATP6V1E1, B3GALTL, B3GAT3, COG1, COG7, DOLK, DPM3, FKRP, FKTN, GMPPB, MPDU1, NPL, PGM1, PIGA, PIGL, PIGN, PIGO, PIGT, PIGV, PMM2, POMT1, POMT2, SRD5A3, XYLT2); 15 carbohydrate-linked lysosomal storage diseases (CTSA, GBA1, GLA, GLB1, HEXB, IDUA, IDS, SGSH, NAGLU, HGSNAT, GNS, GALNS, ARSB, GUSB, ARSK). With this systematic review we aim to raise awareness about the cardiac presentations in carbohydrate-linked IMDs and draw attention to carbohydrate-linked pathogenic mechanisms that may underlie cardiac complications.

Unveiling the link between lactate metabolism and rheumatoid arthritis through integration of bioinformatics and machine learning

“…PIGA participates in phosphatidylinositol production on the endoplasmic reticulum membrane based on N-acetylglucosamine synthesis. Inherited metabolic disorders 37 heavily rely on this reaction. The discovery of UQCRQ suggests that it could serve as a potential biomarker for predicting the response to abatacept/methotrexate in RA patients 38 .…”

Repurposing Normal Chromosomal Microarray Data to Harbor Genetic Insights into Congenital Heart Disease

“…Candidate genes overlapping between this study and genes with de novo variants in the Sifrim et al and Homsy et al exome studies. Genes CTBP1[20] and ATP6V1E1[21] were also found to cause CHD but did not overlap with the exome studies.…”

Discovery of Novel 2-Oxoacetamide Derivatives as B3GAT3 Inhibitors for the Treatment of Hepatocellular Carcinoma

“…Beta-1,3-glucuronosyltransferase (B3GAT3), the first cloned glycosyltransferase, plays a pivotal role in the biosynthesis of sulfated GAGs, converting core proteins into functional PGs and GAGs. Numerous studies have implicated B3GAT3 as an oncogenic factor in cancer development. − For example, increased expression of CS biosynthetic enzymes, including B3GAT3, has been noted in colon and rectal adenocarcinomas . In addition, Zhao et al identified B3GAT3 as an independent risk factor for HCC by analyzing nine genes linked to amino acid metabolism .…”